Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Ribeiro U Jr, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M.

Nat Genet. 2009 Nov;41(11):1238-42. doi: 10.1038/ng.465. Epub 2009 Oct 4.

2.

Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.

Liu Y, Xiong Z, Beasley A, D'Amico T, Chen XL.

Ann N Y Acad Sci. 2016 Oct;1381(1):66-73. doi: 10.1111/nyas.13144. Epub 2016 Jul 11. Review.

PMID:
27399176
3.

The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.

Karachaliou N, Rosell R, Viteri S.

Transl Lung Cancer Res. 2013 Jun;2(3):172-9. doi: 10.3978/j.issn.2218-6751.2013.01.01. Review.

4.

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma.

Daigo Y, Nakamura Y.

Gen Thorac Cardiovasc Surg. 2008 Feb;56(2):43-53. doi: 10.1007/s11748-007-0211-x. Epub 2008 Feb 24. Review.

PMID:
18297458
5.

[New prognostic factors in patients with esophageal squamous carcinoma].

Ueda M.

Gan To Kagaku Ryoho. 1992 Jan;19(1):20-5. Review. Japanese.

PMID:
1530906
6.

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy.

Drilon A, Rekhtman N, Ladanyi M, Paik P.

Lancet Oncol. 2012 Oct;13(10):e418-26. doi: 10.1016/S1470-2045(12)70291-7. Review.

PMID:
23026827
7.

Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis.

Shahryari A, Jazi MS, Samaei NM, Mowla SJ.

Front Genet. 2015 Jun 17;6:196. doi: 10.3389/fgene.2015.00196. eCollection 2015. Review.

8.

Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.

Islamian JP, Mohammadi M, Baradaran B.

Cancer Biol Med. 2014 Jun;11(2):78-85. doi: 10.7497/j.issn.2095-3941.2014.02.002. Review.

Supplemental Content

Support Center